A Study of JS026 and JS026 Together With JS016 for Treatment of COVID-19

NCT05167279 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Shanghai Junshi Bioscience Co., Ltd.